Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor

Vidya Perera, Zhaoqing Wang, Joseph Luettgen, Danshi Li, Mary DeSouza, Michael Cerra, Dietmar Seiffert, Clin Transl Sci. 2022;15:330–342. https://doi.org/10.1111/cts.13148

In the published version of the above article, the authors would like to add the following to the Acknowledgments section:

The authors wish to thank Robert Frost, M.D. Ph.D. and Cesare Russo, M.D. for their early contributions to this study.